Ekso Bionics

Ekso Bionics

Ekso Bionics EksoNR

The Ekso Bionics EksoNR is the clinical gold standard for robotic gait rehabilitation, FDA-cleared for use with stroke and spinal cord injury patients. EksoNR's SmartAssist technology allows therapists to set variable assistance levels for each leg and adjust in real-time during therapy sessions, providing precise control over the rehabilitation process. At $100,000–$150,000, EksoNR commands a significant premium over Chinese alternatives but is backed by extensive clinical evidence, FDA clearance, and a global installed base of over 400 rehabilitation centers. Ekso Bionics has collected data from over 200 million exoskeleton-assisted steps, providing the deepest clinical insights in the industry. EksoNR is the benchmark against which all rehabilitation exoskeletons are compared.